HMGCR and coronary artery disorder: For exploratory outcomes, inverse-variance-weighted analyses showed a decreased risk for coronary artery disease as well as an increased risk for type 2 diabetes especially associated with genetic variants related to genetically proxied inhibition of HMG-CoA reductase (Supplementary Table 8).